Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
7.86
+0.15 (1.95%)
At close: May 12, 2025, 4:00 PM
7.96
+0.10 (1.27%)
After-hours: May 12, 2025, 7:48 PM EDT
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $605.34 million as of May 12, 2025. Its market cap has increased by 55.78% in one year.
Market Cap
605.34M
Enterprise Value
144.84M
1-Year Change
55.78%
Ranking
Category
Stock Price
$7.86
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $605.34M, an increase of 29.48%. That is a compound annual growth rate of 3.87%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |